Aller au contenu
Sommeil et rythmesÉtude de cohorte3 min read

Higher cardiometabolic index tied to more heart disease in hypertension with sleep apnea

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Associations of the Cardiometabolic Index with the Risk of Cardiovascular Disease in Patients with Hypertension and Obstructive Sleep Apnea: Results of a Longitudinal Cohort Study. · Oxidative medicine and cellular longevity · 2022 · Article original ↗

À retenir

Among 2067 people with hypertension and obstructive sleep apnea followed for a median of 6.83 years, each standard deviation increase in the cardiometabolic index (CMI) was linked to a higher risk of cardiovascular disease (adjusted HR 1.31, 95% CI 1.20-1.43). This is a retrospective cohort from one study in Urumqi, so it shows association in a specific patient group, not that lowering CMI prevents disease.

Study design

Étude de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

People with both high blood pressure and obstructive sleep apnea (OSA) are at high cardiovascular risk, and doctors want simple measures to tell who is at greatest risk. The authors tested whether the cardiometabolic index, which combines blood fats and waist size, relates to new cardiovascular disease, coronary disease and stroke in this group.

Population et méthode

Retrospective cohort study of 2067 participants from the Urumqi Research on Sleep Apnea and Hypertension study. The CMI was calculated as the triglyceride to HDL cholesterol ratio multiplied by the waist-to-height ratio. Participants were split into three groups (T1, T2, T3) by CMI tertile. Cumulative incidence of cardiovascular disease (CVD) was estimated with the Kaplan-Meier method, and Cox models gave adjusted hazard ratios with 95% confidence intervals for CVD, coronary heart disease (CHD) and stroke. The authors also tested whether adding CMI to a baseline risk model improved prediction.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Over a median follow-up of 6.83 years (IQR 5.92-8.00), 326 new CVD events occurred: 121 strokes and 205 cases of coronary heart disease.
  2. 2
    After adjustment, each SD increase in CMI was associated with higher risk of new CVD (HR 1.31; 95% CI 1.20-1.43), new CHD (HR 1.33; 95% CI 1.20-1.48) and new stroke (HR 1.27; 95% CI 1.10-1.47). Subgroup and sensitivity analyses gave similar results.
  3. 3
    Adding CMI to the baseline risk model improved the C-index, continuous net reclassification improvement and integrated discrimination index (all P < 0.001), with similar results for CHD and stroke. The abstract does not give the size of these improvements.

Limites et incertitude

  1. 1
    The retrospective design and a single study population in Urumqi, China, may limit how well the results apply to other people with hypertension and OSA.
  2. 2
    CMI was assessed once, and cardiovascular risk may change as weight, blood fats and treatment change over time.
  3. 3
    The abstract does not give the size of the prediction improvements, so whether CMI adds enough to matter in practice is unclear.
  4. 4
    This reading is based on the abstract only, which does not list which factors were adjusted for.

Mise en perspective

In people with high blood pressure and sleep apnea, a high waist-to-height ratio together with high triglycerides and low HDL cholesterol went with more cardiovascular events, so these measures may be worth discussing at check-ups. This is not a self-diagnosis tool, and decisions about treatment or lifestyle changes belong with your clinician.

Vos données

Waist and height measurements can be tracked at home with a tape measure. Triglycerides and HDL come from a blood test, not a wearable. Measure waist at the same point and time of day, and compare lab results from the same lab over months.

Comprendre ce type de preuve

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Purpose

We aimed to explore the relationship between the cardiometabolic index (CMI) and cardiovascular disease (CVD) and its subtypes (coronary artery disease and stroke) in patients with hypertension and obstructive sleep apnea (OSA).

Methods

We conducted a retrospective cohort study enrolling 2067 participants from the Urumqi Research on Sleep Apnea and Hypertension study. The CMI was calculated as triglyceride to high-density lipoprotein cholesterol ratio × waist-to-height ratio. Participants were divided into three groups (T1, T2, and T3) according to the tertile of CMI. The Kaplan-Meier method helped to calculate the cumulative incidence of CVD in different groups. We assessed the association of CMI with the risk of CVD and CVD subtypes by estimating hazard ratios (HRs) and 95% confidence intervals (CIs) using Cox models.

Results

During a median follow-up of 6.83 years (interquartile range: 5.92-8.00 years), 326 incident CVD were identified, including 121 incident stroke and 205 incident coronary heart disease (CHD). Overall, after adjusting for confounding variables, CMI was positively associated with the risk of new-onset CVD (per SD increment, adjusted HR: 1.31; 95% CI: 1.20, 1.43), new-onset CHD (per SD increment, adjusted HR: 1.33; 95% CI: 1.20, 1.48), and new-onset stroke (per SD increment, adjusted HR: 1.27; 95% CI: 1.10, 1.47). Similar results were obtained in various subgroup and sensitivity analyses. Adding CMI to the baseline risk model for CVD improved the C -index ( P < 0.001), continuous net reclassification improvement ( P < 0.001), and integrated discrimination index ( P < 0.001). Similar results were observed for CHD and stroke.

Conclusion

There was a positive association between CMI levels and the risk of new-onset CVD in patients with hypertension and OSA. This finding suggests that CMI may help identify people at high risk of developing CVD.

Sources et attribution

Associations of the Cardiometabolic Index with the Risk of Cardiovascular Disease in Patients with Hypertension and Obstructive Sleep Apnea: Results of a Longitudinal Cohort Study.

Cai X, Hu J, Wen W, Wang J, Wang M, Liu S, Zhu Q, Hong J, Dang Y, Yao X, Sun L, Zhang D, Luo Q, Li N.

Oxidative medicine and cellular longevity · 2022-06-23

DOI: 10.1155/2022/4914791 ↗PubMed · 35783191 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse d’essais

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

Explications approfondiesLire l’étude →
·Étude de cohorte

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

Explications approfondiesLire l’étude →
·Essai randomisé

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

Explications approfondiesLire l’étude →
·Étude de cohorte

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

Explications approfondiesLire l’étude →
Sommeil et rythmes →